Literature DB >> 18055344

High frequency of BCL2 translocation in Thai patients with follicular lymphomas.

Ponlapat Rojnuckarin1, Thamatorn Assanasen, Atcharaporn Chotipuech, Preecha Ruangvejvorachai, Montakarn Tansatit, Pongsak Wannakrairot, Tanin Intragumtornchai.   

Abstract

Follicular lymphoma is characterized by chromosomal translocation involving BCL2 and immunoglobulin heavy chain genes (IgH). That the incidence of follicular lymphoma and the previously reported frequency of BCL2 translocation are lower in Asians than in Caucasians implies a different molecular pathology. The study of BCL2 rearrangement will yield deeper insights into the pathogenesis of follicular lymphomas and into clinical applications of molecular diagnosis for Asian follicular lymphoma patients. BCL2 /IgH translocation was analyzed in paraffin-embedded tissues from follicular lymphoma patients by using polymerase chain reaction (PCR) analysis of the major breakpoint region (MBR), the intermediate cluster region (ICR), and the minor cluster region. In addition, fluorescence in situ hybridization (FISH) analysis with split-signal BCL2 probes was performed. PCR analysis revealed BCL2 rearrangement in 12 (23.5%) of 51 cases (10 MBR and 2 ICR breakpoints). This frequency is lower than the frequencies reported from Western countries (40%-60%). DNA sequencing of the breakpoints revealed nucleotide insertions suggesting V(D)J recombination-mediated mechanisms. On the other hand, FISH analysis revealed 11 (84.6%) of 13 cases with positive signals for BCL2 translocation. Our results suggest that BCL2 translocation is essential for the pathogenesis of follicular lymphoma in Thai patients. In addition, the data demonstrate the low sensitivity of the PCR for diagnostic testing and suggest that split-signal FISH is the method of choice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055344     DOI: 10.1532/IJH97.A20709

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  23 in total

1.  Detection of t(14;18) in follicular lymphoma by dual-color fluorescence in situ hybridization on paraffin-embedded tissue sections.

Authors:  Yosuke Matsumoto; Kenichi Nomura; Sawako Matsumoto; Kyoji Ueda; Mitsushige Nakao; Kazuhiro Nishida; Hideaki Sakabe; Shohei Yokota; Shigeo Horiike; Hirokazu Nakamine; Shigeo Nakamura; Masafumi Taniwaki
Journal:  Cancer Genet Cytogenet       Date:  2004-04-01

Review 2.  Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.

Authors:  Daphne de Jong
Journal:  J Clin Oncol       Date:  2005-09-10       Impact factor: 44.544

3.  FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples.

Authors:  Richard R Einerson; Paul J Kurtin; Gerald A Dayharsh; Teresa K Kimlinger; Ellen D Remstein
Journal:  Am J Clin Pathol       Date:  2005-09       Impact factor: 2.493

4.  PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time.

Authors:  C E Greer; S L Peterson; N B Kiviat; M M Manos
Journal:  Am J Clin Pathol       Date:  1991-02       Impact factor: 2.493

5.  Non-Hodgkin's lymphomas in Thailand. A retrospective pathologic and clinical analysis of 1391 cases.

Authors:  T Intragumtornchai; P Wannakrairoj; B Chaimongkol; L Bhoopat; A Lekhakula; T Thamprasit; N Suwanwela; C Suthipinthawong; W Prayoonwiwat; P Meekungwal; C Sirijerachai; C Pairojkul
Journal:  Cancer       Date:  1996-10-15       Impact factor: 6.860

6.  Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.

Authors:  J W Vaandrager; E Schuuring; T Raap; K Philippo; K Kleiverda; P Kluin
Journal:  Genes Chromosomes Cancer       Date:  2000-01       Impact factor: 5.006

7.  The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma.

Authors:  S C Peh; J Shaminie; Y C Tai; J Tan; S S Gan
Journal:  Histopathology       Date:  2004-11       Impact factor: 5.087

8.  Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital.

Authors:  S Sukpanichnant; D Sonakul; A Piankijagum; W Wanachiwanawin; G Veerakul; C Mahasandana; V S Tanphaichitr; V Suvatte
Journal:  Cancer       Date:  1998-09-15       Impact factor: 6.860

9.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

10.  bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin-embedded tissue specimens.

Authors:  S Mitani; N Aoki; S Mizutani; M Fujiwara; T Kitagawa; T Uehara; S Mori
Journal:  Jpn J Cancer Res       Date:  1993-01
View more
  1 in total

1.  The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis.

Authors:  Hisakazu Nishimori; Keitaro Matsuo; Yoshinobu Maeda; Yuichiro Nawa; Kazutaka Sunami; Kazuto Togitani; Hidetaka Takimoto; Yasushi Hiramatsu; Toru Kiguchi; Tomofumi Yano; Hiromichi Yamane; Takayuki Tabayashi; Makoto Takeuchi; Masanori Makita; Nobuo Sezaki; Yoshiko Yamasuji; Haruko Sugiyama; Takahiro Tabuchi; Itaru Kataoka; Nobuharu Fujii; Fumihiko Ishimaru; Katsuji Shinagawa; Kazuma Ikeda; Masamichi Hara; Tadashi Yoshino; Mitsune Tanimoto
Journal:  Int J Hematol       Date:  2009-03-27       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.